UnitedHealth Group Incorporated $UNH Shares Sold by Apollon Wealth Management LLC

Apollon Wealth Management LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,515 shares of the healthcare conglomerate’s stock after selling 3,710 shares during the period. Apollon Wealth Management LLC’s holdings in UnitedHealth Group were worth $7,986,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Red Door Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 5.5% in the 1st quarter. Red Door Wealth Management LLC now owns 22,560 shares of the healthcare conglomerate’s stock valued at $6,104,000 after purchasing an additional 1,180 shares during the last quarter. Patriot Financial Group Insurance Agency LLC grew its holdings in shares of UnitedHealth Group by 31.5% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 5,318 shares of the healthcare conglomerate’s stock worth $1,439,000 after purchasing an additional 1,275 shares during the period. MeadowBrook Investment Advisors LLC lifted its position in UnitedHealth Group by 9.0% during the first quarter. MeadowBrook Investment Advisors LLC now owns 4,429 shares of the healthcare conglomerate’s stock valued at $1,198,000 after buying an additional 367 shares in the last quarter. Skylands Capital LLC increased its position in shares of UnitedHealth Group by 20.9% in the first quarter. Skylands Capital LLC now owns 9,695 shares of the healthcare conglomerate’s stock worth $2,623,000 after acquiring an additional 1,675 shares in the last quarter. Finally, Janney Montgomery Scott LLC lifted its holdings in shares of UnitedHealth Group by 22.8% during the 1st quarter. Janney Montgomery Scott LLC now owns 264,200 shares of the healthcare conglomerate’s stock valued at $71,490,000 after acquiring an additional 49,092 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $419.30 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $427.93. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. The company has a market cap of $380.78 billion, a PE ratio of 31.67, a P/E/G ratio of 1.72 and a beta of 0.64. The stock has a 50 day simple moving average of $385.98 and a 200-day simple moving average of $333.18.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 18.32 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio is 70.09%.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Bank of America raised its price target on UnitedHealth Group and kept a Buy rating, reinforcing bullish expectations for the stock. BofA Raises PT on UnitedHealth Group (UNH), Keeps a Buy Rating
• Positive Sentiment: Investors are looking ahead to UnitedHealth’s second-quarter earnings on July 16, and anticipation around the report is keeping attention on the name. Should You Buy UnitedHealth Group Stock Before July 16?
• Neutral Sentiment: Market commentary continues to include UnitedHealth among healthcare stocks worth watching, reflecting ongoing investor focus on the sector rather than a company-specific catalyst. Top Healthcare Stocks To Keep An Eye On – June 28th
• Neutral Sentiment: One article suggested a mixed view on unpopular stocks more broadly, but it did not provide a clear new negative catalyst specific to UnitedHealth. 2 Unpopular Stocks That Deserve a Second Chance and 1 We Avoid

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Bank of America increased their price target on UnitedHealth Group from $450.00 to $475.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. Cantor Fitzgerald reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, June 11th. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $420.00 to $466.00 and gave the stock an “overweight” rating in a research note on Monday, June 8th. Morgan Stanley lifted their target price on UnitedHealth Group from $395.00 to $453.00 and gave the company an “overweight” rating in a research note on Thursday, June 4th. Finally, Erste Group Bank upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $410.79.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.